Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AKI | Ann: Removal from Official List at COB 20/03/2012 | 19/03/12 | 0 | 680 | |||
|
|||||||
AKI | Ann: Delisting from ASX and Board of Director cha | 16/03/12 | 0 | 655 | |||
|
|||||||
AKI | Ann: Ceasing to be a substantial holder | 16/03/12 | 0 | 573 | |||
|
|||||||
AKI | Ann: Half Year Accounts | 15/03/12 | 0 | 610 | |||
|
|||||||
AKI | Ann: Suspension from Official Quotation - 15.03.2 | 08/03/12 | 0 | 606 | |||
|
|||||||
AKI | Ann: Resignation of Non-Executive Director Mr To | 08/03/12 | 0 | 506 | |||
|
|||||||
AKI | Ann: Final Director's Interest Notice | 08/03/12 | 0 | 552 | |||
|
|||||||
AKI | Ann: Compulsory Acquisition by Exxaro Australia | 07/03/12 | 0 | 528 | |||
|
See All Discussions